Nuova Zelanda - inglese - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - meropenem trihydrate 570.475mg equivalent to meropenem 500 mg - powder for injection - 500 mg - active: meropenem trihydrate 570.475mg equivalent to meropenem 500 mg excipient: nitrogen sodium carbonate - dbl meropenem for injection is indicated for treatment of the following infections, in adults and children (aged 3 months and over), when the causative organisms are known or suspected to be resistant to commonly used antibiotics: · community acquired lower respiratory tract infection · hospital acquired lower respiratory tract infection · complicated urinary tract infection · febrile neutropenia · intra-abdominal and gynaecological (polymicrobial) infections · complicated skin and skin structure infections · meningitis · septicaemia

Nuova Zelanda - inglese - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - diazepam 4 mg/ml - enema - 10mg/2.5ml - active: diazepam 4 mg/ml excipient: benzoic acid benzyl alcohol ethanol propylene glycol purified water sodium benzoate - for the treatment of febrile and childhood convulsions, where rapid onset of anticonvulsant therapy is imperative.

Nuova Zelanda - inglese - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - diazepam 2 mg/ml - enema - 5mg/2.5ml - active: diazepam 2 mg/ml excipient: benzoic acid benzyl alcohol ethanol propylene glycol purified water sodium benzoate - for the treatment of febrile and childhood convulsions, where rapid onset of anticonvulsant therapy is imperative.

Israele - inglese - Ministry of Health

merck sharp & dohme israel ltd - caspofungin as acetate - powder for concentrate for solution for infusion - caspofungin as acetate 50 mg/vial - caspofungin - caspofungin - cancidas is indicated in adults and pediatric patients (3 months and older) for:- empirical therapy for presumed fungal infections in febrile, neutropenic patients.- treatment of candidemia and the following candida infections: intra-abdominal abscesses, peritonitis and pleural space infections. cancidas has not been studied in endocarditis, ostemyelitis, and meningitis due to candida.- treatment of esophageal candidiasis.- treatment of invasive aspergillosis in patients who are refractory to or intolerant to other therapies (i.e. amphotericin b, lipid formulations of amphotericin b, and/or itraconazole). cancidas has not been studied as initial therapy for invasive aspergillosis.

Israele - inglese - Ministry of Health

merck sharp & dohme israel ltd - caspofungin as acetate - powder for concentrate for solution for infusion - caspofungin as acetate 70 mg/vial - caspofungin - caspofungin - cancidas is indicated in adults and pediatric patients (3 months and older) for:- empirical therapy for presumed fungal infections in febrile, neutropenic patients.- treatment of candidemia and the following candida infections: intra-abdominal abscesses, peritonitis and pleural space infections. cancidas has not been studied in endocarditis, ostemyelitis, and meningitis due to candida.- treatment of esophageal candidiasis.- treatment of invasive aspergillosis in patients who are refractory to or intolerant to other therapies (i.e. amphotericin b, lipid formulations of amphotericin b, and/or itraconazole). cancidas has not been studied as initial therapy for invasive aspergillosis.

Israele - inglese - Ministry of Health

neopharm ltd - azacitidine - lyophilized powder for suspension for sc injection / solution for infusion - azacitidine 100 mg/vial - azacitidine - azacitidine - for the treatment of patients with the following fab myelodysplastic syndromes subtypes: refractory anemia or refractory anemia with ringed sideroblasts ( if accompanied by neutropenia or thrombocytopenia or requiring transfusions),refractory anaemia with excess blasts, refractory anaemia with excess blasts in transformation, and chronic myelomonocytic leukaema.

Israele - inglese - Ministry of Health

megapharm ltd - trabectedin - powder for concentrate for solution for injection - trabectedin 1 mg/vial - trabectedin - trabectedin - yondelis is indicated for the treatment of patients with advanced soft tissue sarcoma, after failure of anthracyclines and ifosfamide, or who are unsuited to receive these agents. efficacy data are based mainly on liposarcoma and leiomyosarcoma patients.

Israele - inglese - Ministry of Health

abic marketing ltd, israel - carboplatin - concentrate for solution for infusion - carboplatin 10 mg/ml - carboplatin - carboplatin - advanced ovarian carcinoma in initial treatment and secondary treatment.metastatic small cell carcinoma of the lung.

Israele - inglese - Ministry of Health

roche pharmaceuticals (israel) ltd - trastuzumab - solution for infusion - trastuzumab 440 mg/ml - trastuzumab - trastuzumab - herceptin is indicated for the treatment of patients with metastatic breast cancer who have tumours that overexpress her2: 1. as a single agent for the treatment of those patients who have received one or more chemotherapy regiments for their metastatic disease. 2. in combination with paclitaxel or docetaxel for the treatment of those patients who have not received chemotherapy for their metastatic disease. 3. herceptin in combination with an aromatase inhibitor for the treatment of postmenopausal patients with hormone-receptor positive metastatic breast cancer. early breast cancer (ebc) :herceptin is indicated to treat patients with her2-positive early breast cancer following surgery and chemotherapy (neoadjuvant or adjuvant) either alone or in combination with chemotherapy excluding anthracyclines. herceptin should only be used in patients whose tumors have either her2 overexpression or her2 gene amplification as determined by an accurate and validated assay.her2 metastatic gastric cancer (mgc)herceptin in combination with capecitabine or 5-fluorouracil and cisplatin is indicated for the treatment of patients with her2 positive metastatic adenocarcinoma of the stomach or gastro-esophageal junction who have not received prior anti-cancer treatment for their metastatic disease.herceptin should only be used in patients with metastatic gastric cancer whose tumours have her2 overexpression as defined by ihc2+ and a confirmatory fish+ result, or ihc 3+, as determined by an accurate and validated assay

Israele - inglese - Ministry of Health

bristol, myers squibb (israel) limited, israel - dasatinib - film coated tablets - dasatinib 100 mg - dasatinib - dasatinib - treatment of adult patients with : * newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. * chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib mesilate. * ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy.